These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 23331044)

  • 1. EFhd2 is a novel amyloid protein associated with pathological tau in Alzheimer's disease.
    Ferrer-Acosta Y; Rodríguez-Cruz EN; Orange F; De Jesús-Cortés H; Madera B; Vaquer-Alicea J; Ballester J; Guinel MJ; Bloom GS; Vega IE
    J Neurochem; 2013 Jun; 125(6):921-31. PubMed ID: 23331044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau's Three-Repeat Domain and EFhd2 Co-incubation Leads to Increased Thioflavin Signal.
    Vega IE; Sutter A; Parks L; Umstead A; Ivanova MI
    Front Neurosci; 2018; 12():879. PubMed ID: 30559642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel calcium-binding protein is associated with tau proteins in tauopathy.
    Vega IE; Traverso EE; Ferrer-Acosta Y; Matos E; Colon M; Gonzalez J; Dickson D; Hutton M; Lewis J; Yen SH
    J Neurochem; 2008 Jul; 106(1):96-106. PubMed ID: 18346207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EFhd2 Affects Tau Liquid-Liquid Phase Separation.
    Vega IE; Umstead A; Kanaan NM
    Front Neurosci; 2019; 13():845. PubMed ID: 31456657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EFhd2 co-aggregates with monomeric and filamentous tau
    Soliman AS; Umstead A; Lamp J; Vega IE
    Front Neurosci; 2024; 18():1373410. PubMed ID: 38765673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cdk5 phosphorylation of EFhd2 at S74 affects its calcium binding activity.
    Vázquez-Rosa E; Rodríguez-Cruz EN; Serrano S; Rodríguez-Laureano L; Vega IE
    Protein Sci; 2014 Sep; 23(9):1197-207. PubMed ID: 24917152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau-proximity ligation assay reveals extensive previously undetected pathology prior to neurofibrillary tangles in preclinical Alzheimer's disease.
    Bengoa-Vergniory N; Velentza-Almpani E; Silva AM; Scott C; Vargas-Caballero M; Sastre M; Wade-Martins R; Alegre-Abarrategui J
    Acta Neuropathol Commun; 2021 Jan; 9(1):18. PubMed ID: 33509301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
    Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
    J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EFhd2 brain interactome reveals its association with different cellular and molecular processes.
    Soliman AS; Umstead A; Grabinski T; Kanaan NM; Lee A; Ryan J; Lamp J; Vega IE
    J Neurochem; 2021 Dec; 159(6):992-1007. PubMed ID: 34543436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein.
    Gomes LA; Hipp SA; Rijal Upadhaya A; Balakrishnan K; Ospitalieri S; Koper MJ; Largo-Barrientos P; Uytterhoeven V; Reichwald J; Rabe S; Vandenberghe R; von Arnim CAF; Tousseyn T; Feederle R; Giudici C; Willem M; Staufenbiel M; Thal DR
    Acta Neuropathol; 2019 Dec; 138(6):913-941. PubMed ID: 31414210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative proteomics of tau and Aβ in detergent fractions from Alzheimer's disease brains.
    Mukherjee S; Dubois C; Perez K; Varghese S; Birchall IE; Leckey M; Davydova N; McLean C; Nisbet RM; Roberts BR; Li QX; Masters CL; Streltsov VA
    J Neurochem; 2023 Feb; 164(4):529-552. PubMed ID: 36271678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with Sarkosyl insoluble PHF-tau decrease neurofibrillary tangles formation in aged tau transgenic mouse model: a pilot study.
    Ando K; Kabova A; Stygelbout V; Leroy K; Heraud C; Frédérick C; Suain V; Yilmaz Z; Authelet M; Dedecker R; Potier MC; Duyckaerts C; Brion JP
    J Alzheimers Dis; 2014; 40 Suppl 1():S135-45. PubMed ID: 24614899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional and structural analysis of the conserved EFhd2 protein.
    Ferrer-Acosta Y; Rodríguez Cruz EN; Vaquer Adel C; Vega IE
    Protein Pept Lett; 2013 May; 20(5):573-83. PubMed ID: 22973849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Alzheimer-type lesions in cognitively normal subjects.
    Tsartsalis S; Xekardaki A; Hof PR; Kövari E; Bouras C
    Neurobiol Aging; 2018 Feb; 62():34-44. PubMed ID: 29107845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of microglia in processing and spreading of bioactive tau seeds in Alzheimer's disease.
    Hopp SC; Lin Y; Oakley D; Roe AD; DeVos SL; Hanlon D; Hyman BT
    J Neuroinflammation; 2018 Sep; 15(1):269. PubMed ID: 30227881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody.
    Albert M; Mairet-Coello G; Danis C; Lieger S; Caillierez R; Carrier S; Skrobala E; Landrieu I; Michel A; Schmitt M; Citron M; Downey P; Courade JP; Buée L; Colin M
    Brain; 2019 Jun; 142(6):1736-1750. PubMed ID: 31038156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial model of amyloid β and tau reveals synergy between amyloid deposits and tangle formation.
    Koller EJ; Ibanez KR; Vo Q; McFarland KN; Gonzalez De La Cruz E; Zobel L; Williams T; Xu G; Ryu D; Patel P; Giasson BI; Prokop S; Chakrabarty P
    Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12779. PubMed ID: 34825397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of WAVE accumulation in Abeta/APP pathology-dependent tangle modification in Alzheimer's disease.
    Takata K; Kitamura Y; Nakata Y; Matsuoka Y; Tomimoto H; Taniguchi T; Shimohama S
    Am J Pathol; 2009 Jul; 175(1):17-24. PubMed ID: 19497998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.